News

AbbVie, North Chicago

AbbVie to Invest $195M in Chicago Manufacturing Plant
AbbVie will invest $195 million in its North Chicago, Illinois, manufacturing plant to expand domestic API production in the U.S.
AbbVie to invest $195 million in North Chicago facility that will produce active pharmaceutical ingredients
Construction on the site will begin in the fall and is expected to be finished by 2027. North Chicago is already home to corporate offices and manufacturing sites for AbbVie.
AbbVie (ABBV) Invests US$195 Million To Expand U.S. Pharmaceutical Production
AbbVie (ABBV) announced a $195 million investment in its North Chicago manufacturing facility to boost domestic API production, reflecting its long-term commitment to U.S. manufacturing. Over the last quarter,
AbbVie to invest $195 million in US drug ingredient manufacturing
AbbVie will invest $195M to expand API manufacturing at its North Chicago plant, boosting U.S. pharmaceutical innovation, jobs, and production of next-generation medicines.
Wintrust Business Minute: AbbVie to spend $200 million to expand North Chicago manufacturing plant
Steve Grzanich has the business news of the day with the Wintrust Business Minute. Abbott Laboratories spinoff AbbVie will spend nearly $200 million to expand its manufacturing plant in North
AbbVie plans $195M API plant in Illinois as part of US investment campaign
As pharma companies big and small play up their U.S. investment plans during the second Trump administration, the particulars of one project at AbbVie are coming into focus. | As pharmas play up their U.
AbbVie to Invest $195 Million in US API Manufacturing
The company’s commitment to its North Chicago, Ill. plant is part of a previously announced $10 billion capital investment earmarked for the expansion of US innovation and manufacturing capacity.
Illinois secures AbbVie’s $195 million investment for North Chicago facility
AbbVie, the maker of Botox, Humira, and Rinvoq, will invest $195 million to expand its North Chicago manufacturing facility, creating at least 50 new jobs within the next three years.
AbbVie announces $195M investment to expand API manufacturing in U.S.
AbbVie (ABBV) announced a $195M investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ingredient
AbbVie to invest $195M to build plant in Illinois
AbbVie (NYSE:ABBV) invests $195M in North Chicago for API production, boosting U.S. pharmaceutical manufacturing. Read more here.
Investor's Business Daily on MSN1h

Stocks Generating Improved Relative Strength: AbbVie

The Relative Strength (RS) Rating for AbbVie ABBV moved into a higher percentile Thursday, as it got a lift from 64 to 71. Please watch the video at Investors.com - Do Your Stocks Meet This Key ...
BioPharma Dive1d

AbbVie to build API plant in Illinois as it steps up US production

The expansion is part of AbbVie’s larger $10 billion commitment to U.S. investment in the face of Trump’s tariff threats.
PharmExec23h

AbbVie Latest to Commit to New US Manufacturing Growth Projects, Committing $195 Million to Expand API Capabilities

The project aims to enhance AbbVie’s chemical synthesis capacity to support next-generation neuroscience, immunology, and ...
TipRanks on MSN23h

AbbVie’s Promising Study on Mirvetuximab Soravtansine for Platinum-Resistant Ovarian Cancer

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a study titled ‘A Randomized ...

AbbVie sees no outsized tariff exposure, boosts profit forecast

AbbVie said on Thursday its tariff exposure is not expected to exceed that of rivals, and raised its 2025 profit forecast ...